10-Q Filing

ALIGNMENT HEALTHCARE, INC. CIK: 1832466 Q3 2025

Filing Information

Form Type	10-Q
Accession Number	`0001628280-25-047538`
Period End Date	20250930
Filing Date	20251030
Fiscal Year	2025
Fiscal Period	Q3
XBRL Instance	alhc-20250930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 154 Income Statement 160 Cash Flow Statement 174 Stockholders Equity 66

Balance Sheet 154 line items

Line Item	Tag	Value	Unit	Period
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	-	USD	Point-in-time
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	-	USD	Point-in-time
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	$548.00K	USD	Point-in-time
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	$548.00K	USD	Point-in-time
Preferred stock par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$340.30M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$340.30M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$432.86M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$432.86M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$618.07M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$618.07M	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Accounts receivable (less allowance for credit losses of $548 at September 30, 2025 and $0 at December 31, 2024)	`AccountsReceivableNetCurrent`	$153.90M	USD	Point-in-time
Accounts receivable (less allowance for credit losses of $548 at September 30, 2025 and $0 at December 31, 2024)	`AccountsReceivableNetCurrent`	$153.90M	USD	Point-in-time
Accounts receivable (less allowance for credit losses of $548 at September 30, 2025 and $0 at December 31, 2024)	`AccountsReceivableNetCurrent`	$219.84M	USD	Point-in-time
Accounts receivable (less allowance for credit losses of $548 at September 30, 2025 and $0 at December 31, 2024)	`AccountsReceivableNetCurrent`	$219.84M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Investments - current	`ShortTermInvestments`	$37.79M	USD	Point-in-time
Investments - current	`ShortTermInvestments`	$37.79M	USD	Point-in-time
Investments - current	`ShortTermInvestments`	$26.01M	USD	Point-in-time
Investments - current	`ShortTermInvestments`	$26.01M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$37.08M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$37.08M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$121.41M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$121.41M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$661.64M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$661.64M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$985.32M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$985.32M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	191.78M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	191.78M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	199.99M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	199.99M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$67.14M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$67.14M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$67.02M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$67.02M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	191.78M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	191.78M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	199.99M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	199.99M	shares	Point-in-time
Right of use asset, net	`LeaseRightOfUseAssets`	$7.82M	USD	Point-in-time
Right of use asset, net	`LeaseRightOfUseAssets`	$7.82M	USD	Point-in-time
Right of use asset, net	`LeaseRightOfUseAssets`	$7.34M	USD	Point-in-time
Right of use asset, net	`LeaseRightOfUseAssets`	$7.34M	USD	Point-in-time
Goodwill	`Goodwill`	$34.83M	USD	Point-in-time
Goodwill	`Goodwill`	$34.83M	USD	Point-in-time
Goodwill	`Goodwill`	$32.06M	USD	Point-in-time
Goodwill	`Goodwill`	$32.06M	USD	Point-in-time
Intangible Assets, net	`IntangibleAssetsNetExcludingGoodwill`	$4.55M	USD	Point-in-time
Intangible Assets, net	`IntangibleAssetsNetExcludingGoodwill`	$4.55M	USD	Point-in-time
Intangible Assets, net	`IntangibleAssetsNetExcludingGoodwill`	$4.55M	USD	Point-in-time
Intangible Assets, net	`IntangibleAssetsNetExcludingGoodwill`	$4.55M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.09M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.09M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.33M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.33M	USD	Point-in-time
Total assets	`Assets`	$782.06M	USD	Point-in-time
Total assets	`Assets`	$782.06M	USD	Point-in-time
Total assets	`Assets`	$1.10B	USD	Point-in-time
Total assets	`Assets`	$1.10B	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$289.79M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$289.79M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$528.80M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$528.80M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$22.13M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$22.13M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$34.01M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$34.01M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$39.93M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$39.93M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$48.28M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$48.28M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$351.85M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$351.85M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$611.09M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$611.09M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$321.43M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$321.43M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$322.74M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$322.74M	USD	Point-in-time
Long-term portion of lease liabilities	`LeaseLiabilityNoncurrent`	$7.83M	USD	Point-in-time
Long-term portion of lease liabilities	`LeaseLiabilityNoncurrent`	$7.83M	USD	Point-in-time
Long-term portion of lease liabilities	`LeaseLiabilityNoncurrent`	$6.92M	USD	Point-in-time
Long-term portion of lease liabilities	`LeaseLiabilityNoncurrent`	$6.92M	USD	Point-in-time
Total liabilities	`Liabilities`	$681.11M	USD	Point-in-time
Total liabilities	`Liabilities`	$681.11M	USD	Point-in-time
Total liabilities	`Liabilities`	$940.74M	USD	Point-in-time
Total liabilities	`Liabilities`	$940.74M	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 shares authorized as of September 30, 2025 and December 31, 2024, respectively; no shares issued and outstanding as of September 30, 2025 and December 31, 2024	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 shares authorized as of September 30, 2025 and December 31, 2024, respectively; no shares issued and outstanding as of September 30, 2025 and December 31, 2024	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 shares authorized as of September 30, 2025 and December 31, 2024, respectively; no shares issued and outstanding as of September 30, 2025 and December 31, 2024	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 shares authorized as of September 30, 2025 and December 31, 2024, respectively; no shares issued and outstanding as of September 30, 2025 and December 31, 2024	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 shares authorized as of September 30, 2025 and December 31, 2024; 199,988,515 and 191,778,639 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively	`CommonStockValue`	$192.00K	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 shares authorized as of September 30, 2025 and December 31, 2024; 199,988,515 and 191,778,639 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively	`CommonStockValue`	$192.00K	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 shares authorized as of September 30, 2025 and December 31, 2024; 199,988,515 and 191,778,639 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively	`CommonStockValue`	$200.00K	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 shares authorized as of September 30, 2025 and December 31, 2024; 199,988,515 and 191,778,639 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively	`CommonStockValue`	$200.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.11B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.11B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.16B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.16B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.01B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.01B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-998.01M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-998.01M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$99.85M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$99.85M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$161.87M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$161.87M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$1.10M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$1.10M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	-	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	-	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$124.80M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$124.80M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$115.63M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$115.63M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$100.95M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$100.95M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$140.97M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$140.97M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$161.87M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$161.87M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$782.06M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$782.06M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$1.10B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$1.10B	USD	Point-in-time

Income Statement 160 line items

Line Item	Tag	Value	Unit	Period
Earned premiums	`PremiumsEarnedNet`	$684.50M	USD	1 Quarter
Earned premiums	`PremiumsEarnedNet`	$684.50M	USD	1 Quarter
Earned premiums	`PremiumsEarnedNet`	$1.98B	USD	3 Qtrs
Earned premiums	`PremiumsEarnedNet`	$1.98B	USD	3 Qtrs
Earned premiums	`PremiumsEarnedNet`	$983.68M	USD	1 Quarter
Earned premiums	`PremiumsEarnedNet`	$983.68M	USD	1 Quarter
Earned premiums	`PremiumsEarnedNet`	$2.91B	USD	3 Qtrs
Earned premiums	`PremiumsEarnedNet`	$2.91B	USD	3 Qtrs
Other	`OtherIncome`	$7.94M	USD	1 Quarter
Other	`OtherIncome`	$7.94M	USD	1 Quarter
Other	`OtherIncome`	$22.17M	USD	3 Qtrs
Other	`OtherIncome`	$22.17M	USD	3 Qtrs
Other	`OtherIncome`	$10.01M	USD	1 Quarter
Other	`OtherIncome`	$10.01M	USD	1 Quarter
Other	`OtherIncome`	$27.99M	USD	3 Qtrs
Other	`OtherIncome`	$27.99M	USD	3 Qtrs
Total revenues	`Revenues`	$692.43M	USD	1 Quarter
Total revenues	`Revenues`	$692.43M	USD	1 Quarter
Total revenues	`Revenues`	$2.00B	USD	3 Qtrs
Total revenues	`Revenues`	$2.00B	USD	3 Qtrs
Total revenues	`Revenues`	$993.70M	USD	1 Quarter
Total revenues	`Revenues`	$993.70M	USD	1 Quarter
Total revenues	`Revenues`	$2.94B	USD	3 Qtrs
Total revenues	`Revenues`	$2.94B	USD	3 Qtrs
Medical expenses	`MedicalExpenses`	$613.44M	USD	1 Quarter
Medical expenses	`MedicalExpenses`	$613.44M	USD	1 Quarter
Medical expenses	`MedicalExpenses`	$1.79B	USD	3 Qtrs
Medical expenses	`MedicalExpenses`	$1.79B	USD	3 Qtrs
Medical expenses	`MedicalExpenses`	$868.02M	USD	1 Quarter
Medical expenses	`MedicalExpenses`	$868.02M	USD	1 Quarter
Medical expenses	`MedicalExpenses`	$2.57B	USD	3 Qtrs
Medical expenses	`MedicalExpenses`	$2.57B	USD	3 Qtrs
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$90.87M	USD	1 Quarter
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$90.87M	USD	1 Quarter
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$269.25M	USD	3 Qtrs
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$269.25M	USD	3 Qtrs
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$110.02M	USD	1 Quarter
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$110.02M	USD	1 Quarter
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$317.64M	USD	3 Qtrs
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$317.64M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$7.64M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$7.64M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$20.11M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$20.11M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$7.98M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$7.98M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$22.57M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$22.57M	USD	3 Qtrs
Total expenses	`OperatingExpenses`	$711.96M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$711.96M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$2.08B	USD	3 Qtrs
Total expenses	`OperatingExpenses`	$2.08B	USD	3 Qtrs
Total expenses	`OperatingExpenses`	$986.01M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$986.01M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$2.91B	USD	3 Qtrs
Total expenses	`OperatingExpenses`	$2.91B	USD	3 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$-19.52M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$-19.52M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$-79.01M	USD	3 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$-79.01M	USD	3 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$7.68M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$7.68M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$25.04M	USD	3 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$25.04M	USD	3 Qtrs
Interest expense	`InterestExpenseNonoperating`	$6.94M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$6.94M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$18.05M	USD	3 Qtrs
Interest expense	`InterestExpenseNonoperating`	$18.05M	USD	3 Qtrs
Interest expense	`InterestExpenseNonoperating`	$3.95M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$3.95M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$11.85M	USD	3 Qtrs
Interest expense	`InterestExpenseNonoperating`	$11.85M	USD	3 Qtrs
Other income, net	`OtherNonoperatingIncomeExpense`	$22.00K	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$22.00K	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$72.00K	USD	3 Qtrs
Other income, net	`OtherNonoperatingIncomeExpense`	$72.00K	USD	3 Qtrs
Other income, net	`OtherNonoperatingIncomeExpense`	-	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	-	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$89.00K	USD	3 Qtrs
Other income, net	`OtherNonoperatingIncomeExpense`	$89.00K	USD	3 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-6.92M	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-6.92M	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-17.98M	USD	3 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-17.98M	USD	3 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-3.95M	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-3.95M	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-11.76M	USD	3 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-11.76M	USD	3 Qtrs
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-26.44M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-26.44M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-96.99M	USD	3 Qtrs
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-96.99M	USD	3 Qtrs
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$3.73M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$3.73M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$13.28M	USD	3 Qtrs
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$13.28M	USD	3 Qtrs
Provision (benefit) for income taxes	`IncomeTaxExpenseBenefit`	$-8.00K	USD	1 Quarter
Provision (benefit) for income taxes	`IncomeTaxExpenseBenefit`	$-8.00K	USD	1 Quarter
Provision (benefit) for income taxes	`IncomeTaxExpenseBenefit`	$14.00K	USD	3 Qtrs
Provision (benefit) for income taxes	`IncomeTaxExpenseBenefit`	$14.00K	USD	3 Qtrs
Provision (benefit) for income taxes	`IncomeTaxExpenseBenefit`	$2.00K	USD	1 Quarter
Provision (benefit) for income taxes	`IncomeTaxExpenseBenefit`	$2.00K	USD	1 Quarter
Provision (benefit) for income taxes	`IncomeTaxExpenseBenefit`	$3.25M	USD	3 Qtrs
Provision (benefit) for income taxes	`IncomeTaxExpenseBenefit`	$3.25M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-26.43M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-26.43M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-97.01M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-97.01M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$3.73M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$3.73M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$10.03M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$10.03M	USD	3 Qtrs
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-16.00K	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-16.00K	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-63.00K	USD	3 Qtrs
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-63.00K	USD	3 Qtrs
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-254.00K	USD	3 Qtrs
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-254.00K	USD	3 Qtrs
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-26.41M	USD	1 Quarter
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-26.41M	USD	1 Quarter
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-96.94M	USD	3 Qtrs
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-96.94M	USD	3 Qtrs
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$3.73M	USD	1 Quarter
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$3.73M	USD	1 Quarter
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$10.28M	USD	3 Qtrs
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$10.28M	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.14	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.14	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.51	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.51	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.02	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.02	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.05	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.05	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.14	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.14	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.51	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.51	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.02	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.02	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.05	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.05	USD	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	191.36M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	191.36M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	190.42M	shares	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	190.42M	shares	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	199.03M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	199.03M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	197.01M	shares	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	197.01M	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	191.36M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	191.36M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	190.42M	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	190.42M	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	208.93M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	208.93M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	208.44M	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	208.44M	shares	3 Qtrs

Cash Flow Statement 174 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-26.43M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-26.43M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-97.01M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-97.01M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$3.73M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$3.73M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$10.03M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$10.03M	USD	3 Qtrs
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$28.00K	USD	1 Quarter
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$28.00K	USD	1 Quarter
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$123.00K	USD	3 Qtrs
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$123.00K	USD	3 Qtrs
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$286.00K	USD	1 Quarter
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$286.00K	USD	1 Quarter
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$548.00K	USD	3 Qtrs
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$548.00K	USD	3 Qtrs
Loss on right of use assets	`GainLossOnOperatingLeaseRightOfUseAsset`	$-135.00K	USD	3 Qtrs
Loss on right of use assets	`GainLossOnOperatingLeaseRightOfUseAsset`	$-135.00K	USD	3 Qtrs
Loss on right of use assets	`GainLossOnOperatingLeaseRightOfUseAsset`	-	USD	3 Qtrs
Loss on right of use assets	`GainLossOnOperatingLeaseRightOfUseAsset`	-	USD	3 Qtrs
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$8.00K	USD	3 Qtrs
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$8.00K	USD	3 Qtrs
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$72.00K	USD	3 Qtrs
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$72.00K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$20.25M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$20.25M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$22.65M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$22.65M	USD	3 Qtrs
Amortization-investment discount	`InvestmentIncomeAmortizationOfDiscount`	$2.08M	USD	3 Qtrs
Amortization-investment discount	`InvestmentIncomeAmortizationOfDiscount`	$2.08M	USD	3 Qtrs
Amortization-investment discount	`InvestmentIncomeAmortizationOfDiscount`	$1.04M	USD	3 Qtrs
Amortization-investment discount	`InvestmentIncomeAmortizationOfDiscount`	$1.04M	USD	3 Qtrs
Amortization-debt issuance costs	`AmortizationOfFinancingCosts`	$978.00K	USD	3 Qtrs
Amortization-debt issuance costs	`AmortizationOfFinancingCosts`	$978.00K	USD	3 Qtrs
Amortization-debt issuance costs	`AmortizationOfFinancingCosts`	$1.32M	USD	3 Qtrs
Amortization-debt issuance costs	`AmortizationOfFinancingCosts`	$1.32M	USD	3 Qtrs
Equity-based compensation	`ShareBasedCompensation`	$54.90M	USD	3 Qtrs
Equity-based compensation	`ShareBasedCompensation`	$54.90M	USD	3 Qtrs
Equity-based compensation	`ShareBasedCompensation`	$48.97M	USD	3 Qtrs
Equity-based compensation	`ShareBasedCompensation`	$48.97M	USD	3 Qtrs
Non-cash lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$1.36M	USD	3 Qtrs
Non-cash lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$1.36M	USD	3 Qtrs
Non-cash lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$1.18M	USD	3 Qtrs
Non-cash lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$1.18M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$19.23M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$19.23M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$66.45M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$66.45M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$8.81M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$8.81M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$84.33M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$84.33M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-77.00K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-77.00K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$47.00K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$47.00K	USD	3 Qtrs
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$91.73M	USD	3 Qtrs
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$91.73M	USD	3 Qtrs
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$239.01M	USD	3 Qtrs
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$239.01M	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$2.83M	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$2.83M	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$11.18M	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$11.18M	USD	3 Qtrs
Deferred premium revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-116.00K	USD	3 Qtrs
Deferred premium revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-116.00K	USD	3 Qtrs
Deferred premium revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$5.00K	USD	3 Qtrs
Deferred premium revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$5.00K	USD	3 Qtrs
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-161.00K	USD	3 Qtrs
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-161.00K	USD	3 Qtrs
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$8.35M	USD	3 Qtrs
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$8.35M	USD	3 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-1.49M	USD	3 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-1.49M	USD	3 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-993.00K	USD	3 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-993.00K	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$43.48M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$43.48M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$190.30M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$190.30M	USD	3 Qtrs
Purchase of investments	`PaymentsToAcquireInvestments`	$75.52M	USD	3 Qtrs
Purchase of investments	`PaymentsToAcquireInvestments`	$75.52M	USD	3 Qtrs
Purchase of investments	`PaymentsToAcquireInvestments`	$45.19M	USD	3 Qtrs
Purchase of investments	`PaymentsToAcquireInvestments`	$45.19M	USD	3 Qtrs
Sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$14.00K	USD	3 Qtrs
Sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$14.00K	USD	3 Qtrs
Sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$75.00K	USD	3 Qtrs
Sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$75.00K	USD	3 Qtrs
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfLongtermInvestments`	$152.75M	USD	3 Qtrs
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfLongtermInvestments`	$152.75M	USD	3 Qtrs
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfLongtermInvestments`	$57.99M	USD	3 Qtrs
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfLongtermInvestments`	$57.99M	USD	3 Qtrs
Sale of business	`ProceedsFromDivestitureOfBusinesses`	-	USD	3 Qtrs
Sale of business	`ProceedsFromDivestitureOfBusinesses`	-	USD	3 Qtrs
Sale of business	`ProceedsFromDivestitureOfBusinesses`	$1.06M	USD	3 Qtrs
Sale of business	`ProceedsFromDivestitureOfBusinesses`	$1.06M	USD	3 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$32.13M	USD	3 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$32.13M	USD	3 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$21.75M	USD	3 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$21.75M	USD	3 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$45.11M	USD	3 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$45.11M	USD	3 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-7.81M	USD	3 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-7.81M	USD	3 Qtrs
Proceeds from long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$50.00M	USD	3 Qtrs
Proceeds from long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$50.00M	USD	3 Qtrs
Proceeds from long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	3 Qtrs
Proceeds from long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	3 Qtrs
Payment of employment taxes related to release of restricted stock	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$350.00K	USD	3 Qtrs
Payment of employment taxes related to release of restricted stock	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$350.00K	USD	3 Qtrs
Payment of employment taxes related to release of restricted stock	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	-	USD	3 Qtrs
Payment of employment taxes related to release of restricted stock	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	-	USD	3 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$512.00K	USD	3 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$512.00K	USD	3 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$26.00K	USD	3 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$26.00K	USD	3 Qtrs
Proceeds from stock option exercises	`ProceedsFromStockOptionsExercised`	-	USD	3 Qtrs
Proceeds from stock option exercises	`ProceedsFromStockOptionsExercised`	-	USD	3 Qtrs
Proceeds from stock option exercises	`ProceedsFromStockOptionsExercised`	$2.77M	USD	3 Qtrs
Proceeds from stock option exercises	`ProceedsFromStockOptionsExercised`	$2.77M	USD	3 Qtrs
Contributions from noncontrolling interest holders	`ProceedsFromMinorityShareholders`	$15.00K	USD	3 Qtrs
Contributions from noncontrolling interest holders	`ProceedsFromMinorityShareholders`	$15.00K	USD	3 Qtrs
Contributions from noncontrolling interest holders	`ProceedsFromMinorityShareholders`	-	USD	3 Qtrs
Contributions from noncontrolling interest holders	`ProceedsFromMinorityShareholders`	-	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$49.15M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$49.15M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.75M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.75M	USD	3 Qtrs
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$137.75M	USD	3 Qtrs
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$137.75M	USD	3 Qtrs
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$185.24M	USD	3 Qtrs
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$185.24M	USD	3 Qtrs
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$342.70M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$342.70M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$434.94M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$434.94M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$620.18M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$620.18M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$342.70M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$342.70M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$434.94M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$434.94M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$620.18M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$620.18M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$15.60M	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$15.60M	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$6.74M	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$6.74M	USD	3 Qtrs
Acquisition of property in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$112.00K	USD	3 Qtrs
Acquisition of property in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$112.00K	USD	3 Qtrs
Acquisition of property in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$79.00K	USD	3 Qtrs
Acquisition of property in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$79.00K	USD	3 Qtrs
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$340.30M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$340.30M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$432.86M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$432.86M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$618.07M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$618.07M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$2.40M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$2.40M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$2.11M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$2.11M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$342.70M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$342.70M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$434.94M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$434.94M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$620.18M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$620.18M	USD	Point-in-time

Stockholders Equity 66 line items

Line Item	Tag	Value	Unit	Period
Beginning balance (in shares)	`CommonStockSharesOutstanding`	191.78M	shares	Point-in-time
Beginning balance (in shares)	`CommonStockSharesOutstanding`	191.78M	shares	Point-in-time
Beginning balance (in shares)	`CommonStockSharesOutstanding`	199.99M	shares	Point-in-time
Beginning balance (in shares)	`CommonStockSharesOutstanding`	199.99M	shares	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$124.80M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$124.80M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$115.63M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$115.63M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$100.95M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$100.95M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$140.97M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$140.97M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$161.87M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$161.87M	USD	Point-in-time
Net income (loss)	`ProfitLoss`	$-26.43M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-26.43M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-97.01M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-97.01M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$3.73M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$3.73M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$10.03M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$10.03M	USD	3 Qtrs
Issuance of common stock upon vesting of restricted and performance stock units	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$2.00K	USD	3 Qtrs
Issuance of common stock upon vesting of restricted and performance stock units	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$2.00K	USD	3 Qtrs
Shares withheld related to net restricted stock settlement	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$350.00K	USD	3 Qtrs
Shares withheld related to net restricted stock settlement	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$350.00K	USD	3 Qtrs
Equity-based compensation	`StockGrantedDuringPeriodValueSharebasedCompensation`	$17.26M	USD	1 Quarter
Equity-based compensation	`StockGrantedDuringPeriodValueSharebasedCompensation`	$17.26M	USD	1 Quarter
Equity-based compensation	`StockGrantedDuringPeriodValueSharebasedCompensation`	$54.90M	USD	3 Qtrs
Equity-based compensation	`StockGrantedDuringPeriodValueSharebasedCompensation`	$54.90M	USD	3 Qtrs
Equity-based compensation	`StockGrantedDuringPeriodValueSharebasedCompensation`	$16.23M	USD	1 Quarter
Equity-based compensation	`StockGrantedDuringPeriodValueSharebasedCompensation`	$16.23M	USD	1 Quarter
Equity-based compensation	`StockGrantedDuringPeriodValueSharebasedCompensation`	$48.97M	USD	3 Qtrs
Equity-based compensation	`StockGrantedDuringPeriodValueSharebasedCompensation`	$48.97M	USD	3 Qtrs
Stock options exercised (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	24,472.00	shares	1 Quarter
Stock options exercised (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	24,472.00	shares	1 Quarter
Stock options exercised (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	99,107.00	shares	1 Quarter
Stock options exercised (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	99,107.00	shares	1 Quarter
Stock options exercised (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	104,646.00	shares	1 Quarter
Stock options exercised (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	104,646.00	shares	1 Quarter
Stock options exercised	`StockIssuedDuringPeriodValueStockOptionsExercised`	$948.00K	USD	1 Quarter
Stock options exercised	`StockIssuedDuringPeriodValueStockOptionsExercised`	$948.00K	USD	1 Quarter
Stock options exercised	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.77M	USD	3 Qtrs
Stock options exercised	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.77M	USD	3 Qtrs
Sale of consolidated subsidiary	`NoncontrollingInterestDecreaseFromDeconsolidation`	$850.00K	USD	3 Qtrs
Sale of consolidated subsidiary	`NoncontrollingInterestDecreaseFromDeconsolidation`	$850.00K	USD	3 Qtrs
Repurchase of noncontrolling interest attributable to subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$15.00K	USD	3 Qtrs
Repurchase of noncontrolling interest attributable to subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$15.00K	USD	3 Qtrs
Ending balance (in shares)	`CommonStockSharesOutstanding`	191.78M	shares	Point-in-time
Ending balance (in shares)	`CommonStockSharesOutstanding`	191.78M	shares	Point-in-time
Ending balance (in shares)	`CommonStockSharesOutstanding`	199.99M	shares	Point-in-time
Ending balance (in shares)	`CommonStockSharesOutstanding`	199.99M	shares	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$124.80M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$124.80M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$115.63M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$115.63M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$100.95M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$100.95M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$140.97M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$140.97M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$161.87M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$161.87M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.